PC(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))

YNQXQNOLOMVDLG-HJYHAXFASA-N CHEBI:89557 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: YNQXQNOLOMVDLG-HJYHAXFASA-N
InChI Key: YNQXQNOLOMVDLG-HJYHAXFASA-N
IUPAC name
Preferred name: PC(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
INN name: —
Synonym: GPCho(18:3n6/18:3n6)
ChEBI: CHEBI:89557

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)

Observed in differential profiles

Sham_vs_UIR